Investing

Organon : OGN

OGN

Stock Data

$13.29

$0.04 (0.30%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Organon & Company focuses on improving women's health globally by offering a wide range of prescription therapies and medical devices. Its products include contraceptives like Nexplanon and NuvaRing, fertility treatments such as Follistim AQ, and treatments for postpartum bleeding like Jada. Beyond women's health, Organon also provides biosimilars for immunology and oncology, cholesterol medications, treatments for hypertension and respiratory conditions, dermatology products, bone health solutions, and non-opioid pain management options. Founded in 2020 and based in Jersey City, New Jersey, Organon serves a diverse clientele, including hospitals, pharmacies, and government agencies.

All Organon Articles

2 Articles

Lee Jackson | Apr 28, 2026 at 7:57 AM EDT

Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Homes 4 Rent, BP, Fortis, International Business Machines, Micron Technology, Nucor, Opendoor Technologies, Rambus, and More

Pre-Market Stock Futures: Futures are trading mostly lower after a rather ho-hum start to the trading week on Monday. While…

Gerelyn Terzo | Apr 24, 2026 at 9:58 AM EDT

Nasdaq Composite Rises on Cautious Optimism on Tech Tailwinds but Iran Tensions Loom

The Nasdaq Composite (^IXIC) is trading in the green at Friday’s open, with the index leading the major averages as…